LA HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Kythera Biopharmaceuticals Inc. announced on Tuesday a $125 million secondary offering as it anticipates FDA approval of its lead drug candidate, a drug that reduces double chins.
A Food and Drug Administration panel on Monday recommended approval of Kythera Biopharmaceuticals Inc.’s novel treatment for chin fat.
Amgen Inc. will face new competition after Novartis AG secured the first-ever FDA approval to sell a “biosimilar” drug – provided it can overcome a legal challenge by the Thousand Oaks company.
Pasadena biotechnology company Arrowhead Research Corp. announced today that it had struck a deal to acquire the RNAi research and development portfolio of drug maker Novartis in a deal valued at about $35 million.
Cannabis investment firm Lizada Capital signed a $15 million deal Wednesday that will make it Medbox’s largest shareholder.
Caren Mason, who was elected to implantable lens maker Staar Surgical Co.’s board last June, was named Tuesday as chief executive, replacing Barry Caldwell who retired March 1.
If Herbalife Ltd. Chief Executive Michael Johnson sounded upbeat on the company’s recent earnings call, it likely had nothing to do with his 2014 compensation.
Herbalife Ltd., the embattled downtown Los Angeles nutritional supplement company, reported its fourth quarter earnings, with some disappointing results, after markets closed Thursday.
It’s Official: Attorney General Approves Sale of Daughters of Charity Health System to Prime Healthcare Services
California Attorney General Kamala Harris handed down a hotly anticipated verdict on Friday.
The data breach at Anthem Inc. was broader than initially thought and could affect customers as far back as 2004, according to media reports on Thursday.
Two Los Angeles-area hospitals were among 10 fined by the California Department of Public Health today after investigations found the facilities had not complied with licensing requirements. And their actions caused, or were likely to cause, serious injury or death to patients.
Officials with Anthem Blue Cross Inc. in Thousand Oaks were still determining Thursday how many of its California members may have had personal information compromised by a huge security breach at its parent company.
The contentious fight over the fate of six Daughters of Charity hospitals, including two in Los Angeles County, has been extended by another two weeks. The deadline by which Attorney General Kamala Harris must review and approve the sale of Daughters’ medical centers to Prime Healthcare Services has been pushed to Feb. 20.
Amgen Inc. reported fourth-quarter and full-year financial results on Tuesday that topped analysts’ estimates as the company reaped the benefits of previously announced layoffs, a tax credit and strong drug sales.
Health One Pharmaceuticals Inc., a City of Industry manufacturer of dietary supplements and drugs, has been shut down as part of a consent decree reached with the Department of Justice.